RECRUITING

Risk and Resilience to Suicide Following Late-Life Spousal Bereavement

Talk to us

Conditions

SuicideBereavementgriefgeriatrichealthtechnologydepression

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the RISE study is to examine how the 24-hour rhythm of sleep and social activity relate to mood and suicidal ideation among older adults that recently lost a spouse or life partner.

Official Title

Risk and Resilience to Late-life Suicidal Ideation and Behavior After Spousal Bereavement: Targeting Social Connectedness to Strengthen Circadian Rhythmicity

Quick Facts

Study Start:2023-11-20
Study Completion:2029-12-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06191484

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Bereaved \< or = to 12 months from spousal/partner loss
  2. 2. \> or = to 65 years old
  3. 3. Verified history of suicide attempt/attempts and/or current or past history of Major Depressive Disorder/Major Depressive Episode (MDD/MDE) (without psychotic features), or history of depression severe enough to trigger treatment, or current subsyndromal depression (\> or = to 9 HDRS)
  4. 4. No diagnosis of schizophrenia/schizoaffective disorders/bipolar/current psychosis
  5. 5. Does not reside in nursing home
  6. 6. Not a current shift worker
  7. 7. No major cognitive impairment: TICS score of \> or = to 27
  1. 1. Bereaved \>12 months from spousal/partner bereavement
  2. 2. \< 65 years old
  3. 3. Patient is not spousal/partner bereaved (ex: parent, sibling, etc.)
  4. 4. Prior diagnosis of schizophrenia/schizoaffective disorders/bipolar/current psychosis or medications listed indicate diagnosis of these disorders/MDD or MDE with psychotic features
  5. 5. Major cognitive impairment: TICS score of \<27
  6. 6. Current shift worker
  7. 7. Resides in a nursing home
  8. 8. Unstable medical condition (e.g., unstable angina, end stage renal disease)

Contacts and Locations

Study Contact

Emilee Croswell, BA
CONTACT
4124408418
croswellej@upmc.edu
Sarah Stahl, PhD
CONTACT
sts80@pitt.edu

Principal Investigator

Sarah Stahl, PhD
PRINCIPAL_INVESTIGATOR
University of Pittsburgh

Study Locations (Sites)

University of Pittsburgh (UPMC)
Pittsburgh, Pennsylvania, 15212
United States

Collaborators and Investigators

Sponsor: University of Pittsburgh

  • Sarah Stahl, PhD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-20
Study Completion Date2029-12-01

Study Record Updates

Study Start Date2023-11-20
Study Completion Date2029-12-01

Terms related to this study

Keywords Provided by Researchers

  • grief
  • bereavement
  • suicide
  • geriatric
  • health
  • technology
  • depression

Additional Relevant MeSH Terms

  • Suicide
  • Bereavement